Hydroxyethylrutoside

Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.

Also Known As:

0-beta-Hydroxyethylrutoside; beta-Hydroxyethylrutoside; 0 beta Hydroxyethylrutoside; beta Hydroxyethylrutoside

Networked: 11 relevant articles (1 outcomes, 1 trials/studies)

1.	Venous Insufficiency 10/01/1986 - "[Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency]." 03/01/2000 - "Escin, hydroxyethylrutoside (HR), and Daflon have been shown to be safe and effective for the treatment of chronic venous insufficiency (CVI). " 03/01/2000 - "Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon."
2.	Diabetic Retinopathy (Retinopathy, Diabetic) 01/01/1969 - "[Diabetic retinopathy: study on the action of l'o-beta-hydroxyethylrutoside for retinal fluoresceinography]."
3.	Varicose Veins (Varicose Vein) 01/01/1995 - "[Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy]." 12/01/1993 - "The patient had no history of taking hydroxyethylrutoside, a drug used in Europe in treating varicose veins that has been implicated in all three previously reported cases. "
4.	Cardiotoxicity 04/01/2000 - "7-Monohydroxyethylrutoside (monoHER), a flavonoid belonging to the semisynthetic hydroxyethylrutoside family, has been shown to protect against doxorubicin-induced cardiotoxicity when administered i.p. "
5.	Atherosclerosis 01/01/1989 - "The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis."

1.	Escin
2.	Diosmin (Daflon)
3.	Retinaldehyde (Retinal)
4.	Flavonoids
5.	Adrenergic Antagonists (Antiadrenergic Agents)
6.	Glycerol (Glycerine)
7.	Doxorubicin (Adriamycin)
8.	Aspirin (Acetylsalicylic Acid)
9.	7-monohydroxyethylrutoside